
EC Partnership Victoria
@ecpartnershipau
EC Partnership
Led by Burnet Institute | Partners: Vic DH & Dpt of Justice, Hepatitis Victoria, Harm Reduction Victoria, Alfred Health & St Vincent's Hospital
ID: 821959368316813313
https://ecpartnership.org.au/ 19-01-2017 05:55:59
680 Tweet
183 Followers
178 Following

Freya Saich from EC Australia showing #hepC elimination priorities resulting from a policy analysis and stakeholders consultations #WorldHepatitisDay


"If 2 billionaires had raced to eliminate diseases, one chose #hepB and one chose #hepC, imagine where we'd be," Margaret Hellard says š should be launched in the direction of hepatitis elimination in closing remarks for our #WorldHepatitisDay symposium. Thanks all who attended!


Australia can achieve World Health Organization (WHO) target to eliminate #hepC as public health threat. First, we must find thousands who are unaware of their infection š and get them treated. To reach priority populations we need creative strategies and partnerships. #HepCantWait #WorldHepatitisDay




We spoke with John Dillon from University of Dundee NHS Tayside to discuss how his team became the first region in the world to effectively eliminate #hepatitisC.ā ā inhsu.org/articles/meet-⦠#HCV #Hepc


Great new episode with prof Margaret Hellard. A must listen for all public health professionals š§ Burnet Institute Prof Brendan Crabb Tracy Parish

Melbourne may still be in lockdown. But some of its most iconic landmarks ā AAMI Park, City of Melbourne Town Hall, Flinders St Station and Bolte Bridge ā are still lit up in brilliant purple on International Overdose Awareness Day to honour our lost loved ones, and recognise those living with the loss.


On Ep 7 How Science Matters we talk about the buzzword of the last month: modelling. Hear what's behind #COVID19 modelling and how Margaret Hellard and Dr Nick Scott are helping governments prepare health systems for the virus. Out tomorrow! š§ Subscribe burnet.edu.au/how-science-maā¦


At #INHSU2019 Andrew Radley NHS Tayside presented on the effectiveness of pharmacist-led VS conventionally delivered DAA treatment for #HCV in patients receiving OST, published The Lancet Gastroenterology & Hepatology pubmed.ncbi.nlm.nih.gov/32526210/ Join #INHSU2021 to hear new research! inhsu.org/2021-conferencā¦


Interesting work from Burnet Institute & UNSW Centre for Social Research in Health 'Experiences of #stigma may not necessarily be a barrier to access health services but high rates of health service use may further expose exacerbate or exaggerate stigma among people who inject drugs' doi.org/10.1111/jvh.13ā¦

Pleased to share our International Journal of Drug Policy editorial highlighting the need for person-centred strategies to address HCV, other infectious diseases, and harms that may relate to drug use. Highlights a special issue with nearly 40 papers on these topics sciencedirect.com/science/articlā¦

thanks to everyone who came along to the UNSW Centre for Social Research in Health Spotlight on Stigma #2 session on policy. Here's the link to the recording: youtube.com/watch?v=iS8q24⦠And don't forget to register for #3 - structure and stigma eventbrite.com.au/e/stigma-and-tā¦

Tune in now to the 'Change in Drug Use' session to catch @soph_schroeder presentation shortly Burnet Institute #INHSU2021


Opening presentation by Jacqui Richmond sharing data on significant impact of COVID on testing and treatment for viral hepatitis with 14% decline in hepatitis serology items in 2020 from 2019. Burnet Institute EC Partnership Victoria



Very happy to share our recent paper in Liver International on #HCV care in primary care and community services. More evidence that a) people who currently and/or recently inject drugs can be cured of #HCV & b) treatment in primary care is feasible and effective onlinelibrary.wiley.com/doi/abs/10.111ā¦



JUST PUBLISHED "A global systematic review of hepatitis C elimination efforts through micro-elimination" thieme-connect.de/products/ejour⦠#NoHep @capicchio Javier Crespo Graham Cooke @GregDore2 Jason Grebely Coalition for Global Hepatitis Elimination ISGlobal Seminars in Liver Disease
